77:@0.890196:0.957873:0.907316:0.957873:0.907316:0.938882:0.890196:0.938882:0.008529:0.008591
3:@0.941813:0.310836:0.963291:0.310836:0.963291:0.263358:0.941813:0.263358:0.021478
PATIENT-DERIVED OVARIAN CANCER ORGANOIDS MIMIC CLINICAL RESPONSE AND:@0.411230:0.057372:0.882353:0.057372:0.882353:0.040253:0.411230:0.040253:0.007583:0.007097:0.006387:0.003511:0.006985:0.008759:0.005640:0.005155:0.008423:0.006985:0.008423:0.003511:0.007620:0.006985:0.008423:0.002988:0.008328:0.006966:0.007919:0.008423:0.003511:0.007919:0.008759:0.002988:0.008178:0.007919:0.008759:0.008255:0.006985:0.008423:0.002988:0.008442:0.008311:0.008292:0.007919:0.008759:0.008442:0.003511:0.008423:0.007807:0.002988:0.011112:0.003511:0.011112:0.003511:0.008255:0.002988:0.008255:0.006481:0.003511:0.008759:0.003511:0.008177:0.007919:0.006294:0.002988:0.008423:0.006871:0.007807:0.008050:0.008442:0.008759:0.007807:0.006985:0.002801:0.007919:0.008759:0.008423
EXHIBIT HETEROGENEOUS INTER- AND INTRAPATIENT DRUG RESPONSES:@0.468171:0.073247:0.882352:0.073247:0.882352:0.056128:0.468171:0.056128:0.006985:0.007527:0.008685:0.003511:0.008236:0.003511:0.006201:0.002988:0.008685:0.006985:0.006387:0.006985:0.008309:0.008442:0.008404:0.006985:0.008759:0.006985:0.008442:0.008367:0.007807:0.002988:0.003511:0.008759:0.006387:0.006985:0.008423:0.005155:0.002800:0.007919:0.008759:0.008423:0.002988:0.003511:0.008759:0.006387:0.008423:0.007919:0.007581:0.007097:0.006387:0.003511:0.006985:0.008759:0.006201:0.002988:0.008423:0.008367:0.008367:0.008404:0.002988:0.008423:0.006873:0.007807:0.008050:0.008442:0.008759:0.007807:0.006871:0.007807
Organoid derivation and culture:@0.147059:0.122511:0.436763:0.122511:0.436763:0.099351:0.147059:0.099351:0.011256:0.011081:0.011056:0.010558:0.011679:0.011256:0.004856:0.011231:0.003984:0.011231:0.009363:0.011231:0.004856:0.009286:0.009463:0.008616:0.004856:0.011256:0.011679:0.003735:0.010558:0.011679:0.011231:0.003984:0.011007:0.011156:0.007194:0.008616:0.011156:0.011231:0.009363
Organoids were derived from tumor samples of patients with OC and cultured accord-:@0.147059:0.172078:0.882353:0.172078:0.882353:0.151705:0.147059:0.151705:0.016298:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.004771:0.014518:0.009039:0.007442:0.009039:0.004771:0.011322:0.009039:0.007807:0.005547:0.009633:0.009108:0.011391:0.004771:0.006414:0.007442:0.010843:0.017645:0.004771:0.006163:0.011413:0.017485:0.010843:0.007807:0.004771:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.004771:0.010845:0.006209:0.004771:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.007670:0.004771:0.014723:0.005273:0.006620:0.011459:0.004771:0.016778:0.014678:0.004771:0.009085:0.011596:0.011391:0.004771:0.009108:0.011550:0.004908:0.006163:0.011413:0.007442:0.009108:0.011391:0.004771:0.009291:0.008994:0.008994:0.010843:0.007442:0.011295:0.007533
ing to our previously described protocol . Briefly, tumor tissue was cut into small piec-:@0.147059:0.192656:0.882353:0.192656:0.882353:0.172284:0.147059:0.172284:0.005615:0.011459:0.009861:0.004337:0.006209:0.011048:0.004337:0.010820:0.011413:0.007807:0.004337:0.011071:0.007442:0.009336:0.009838:0.005547:0.010820:0.011413:0.007556:0.005182:0.009724:0.004337:0.011322:0.009039:0.007875:0.008994:0.007807:0.005547:0.011251:0.009108:0.011391:0.004337:0.011071:0.007442:0.010822:0.006209:0.011274:0.008994:0.010934:0.005250:0.018199:0.004497:0.004337:0.012486:0.007807:0.005547:0.009039:0.005638:0.005570:0.007989:0.004497:0.004337:0.006163:0.011413:0.017485:0.010843:0.007807:0.004337:0.006437:0.005615:0.007533:0.007510:0.011345:0.009039:0.004337:0.014723:0.009291:0.007670:0.004337:0.009108:0.011071:0.006437:0.004337:0.005615:0.011391:0.006209:0.011048:0.004337:0.007601:0.017577:0.009405:0.005387:0.005250:0.004337:0.011071:0.005547:0.009108:0.008919:0.007533
278:@0.485190:0.185040:0.503435:0.185040:0.503435:0.173163:0.485190:0.173163:0.006082:0.006082:0.006082
es. Two random pieces were separated for fixation in formalin for histopathological anal-:@0.147059:0.213235:0.882353:0.213235:0.882353:0.192862:0.147059:0.192862:0.009039:0.007670:0.004497:0.003424:0.011756:0.014518:0.011048:0.003424:0.007898:0.009085:0.011596:0.011322:0.010843:0.017645:0.003424:0.011071:0.005547:0.009108:0.008994:0.009039:0.007670:0.003424:0.014518:0.009039:0.007442:0.009039:0.003424:0.007875:0.009128:0.011368:0.009085:0.007898:0.008811:0.006211:0.009106:0.011391:0.003424:0.006026:0.010843:0.007807:0.003424:0.005684:0.005684:0.010089:0.008811:0.006437:0.005547:0.010843:0.011756:0.003424:0.005615:0.011756:0.003424:0.006026:0.010843:0.007807:0.017579:0.009402:0.005250:0.005615:0.011756:0.003424:0.006024:0.010843:0.007807:0.003424:0.011459:0.005615:0.007510:0.006209:0.010820:0.011368:0.008811:0.006620:0.011299:0.010934:0.005182:0.011048:0.009861:0.005547:0.009108:0.009405:0.005250:0.003424:0.009085:0.011687:0.009405:0.005344:0.007533
ysis and DNA isolation. The remaining tissue was minced, washed with 10 ml advanced :@0.147059:0.233814:0.886464:0.233814:0.886464:0.213441:0.147059:0.213441:0.009724:0.007601:0.005615:0.007670:0.004406:0.009085:0.011598:0.011391:0.004406:0.015773:0.015408:0.014929:0.004406:0.005615:0.007875:0.010934:0.005433:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.004406:0.011470:0.011311:0.009039:0.004406:0.007442:0.009039:0.017577:0.009085:0.005615:0.011756:0.005615:0.011459:0.009861:0.004406:0.006437:0.005615:0.007533:0.007510:0.011345:0.009039:0.004406:0.014723:0.009291:0.007670:0.004406:0.017645:0.005615:0.011594:0.008994:0.009108:0.011117:0.004497:0.004406:0.014723:0.009291:0.007556:0.011299:0.009108:0.011391:0.004406:0.014723:0.005273:0.006620:0.011459:0.004406:0.010432:0.010432:0.002945:0.017759:0.005250:0.004406:0.009291:0.011322:0.009838:0.009085:0.011596:0.008994:0.009108:0.011391:0.004109
DMEM/F12 containing 1x Glutamax, 10 mM HEPES and antibiotics (AdDF+++), col-:@0.147059:0.254393:0.882353:0.254393:0.882353:0.234020:0.147059:0.234020:0.015499:0.019608:0.012098:0.019608:0.007099:0.011276:0.010432:0.010432:0.005068:0.008994:0.010843:0.011391:0.006551:0.009085:0.005615:0.011756:0.005615:0.011459:0.009861:0.005068:0.010432:0.010089:0.005068:0.015502:0.004908:0.011069:0.006551:0.009087:0.017577:0.009291:0.010089:0.004497:0.005068:0.010432:0.010432:0.002851:0.017645:0.019608:0.005068:0.016846:0.012098:0.011664:0.012098:0.010112:0.005068:0.009085:0.011596:0.011391:0.005068:0.009085:0.011391:0.006437:0.005547:0.010820:0.005547:0.010820:0.006437:0.005547:0.008994:0.007670:0.005068:0.006939:0.014335:0.011391:0.015773:0.011276:0.011779:0.011779:0.011779:0.006939:0.004497:0.005068:0.008994:0.010934:0.005271:0.007533
lected in a tube, and centrifuged at 300g for 5 minutes. Fragments were allowed to set-:@0.147059:0.274971:0.882353:0.274971:0.882353:0.254598:0.147059:0.254598:0.005182:0.009108:0.009108:0.006209:0.009108:0.011391:0.005250:0.005615:0.011756:0.005250:0.009291:0.005250:0.006163:0.011345:0.011254:0.008743:0.004497:0.005250:0.009085:0.011596:0.011391:0.005250:0.008994:0.009039:0.011391:0.006437:0.007807:0.005615:0.006366:0.011413:0.009656:0.009108:0.011391:0.005250:0.008809:0.006437:0.005250:0.010432:0.010432:0.010432:0.009861:0.005250:0.006026:0.010843:0.007807:0.005250:0.010432:0.005250:0.017645:0.005615:0.011391:0.011071:0.006209:0.009039:0.007670:0.004497:0.005250:0.010751:0.007896:0.009201:0.009861:0.017485:0.009039:0.011393:0.006437:0.007670:0.005250:0.014518:0.009039:0.007442:0.009039:0.005250:0.009405:0.005387:0.005182:0.010866:0.014518:0.009108:0.011391:0.005250:0.006209:0.011048:0.005250:0.007875:0.009131:0.006414:0.007533
tle under normal gravity for 1 minute, and remaining big tissue pieces were digested in :@0.147059:0.295550:0.886578:0.295550:0.886578:0.275177:0.147059:0.275177:0.006620:0.005182:0.009039:0.005045:0.011413:0.011596:0.011322:0.009039:0.007807:0.005045:0.011596:0.010843:0.007807:0.017577:0.009405:0.005250:0.005045:0.009861:0.007898:0.008925:0.009838:0.005273:0.006437:0.009724:0.005045:0.006026:0.010843:0.007807:0.005045:0.010432:0.005045:0.017645:0.005615:0.011391:0.011071:0.006209:0.008743:0.004497:0.005045:0.009087:0.011596:0.011391:0.005045:0.007442:0.009039:0.017577:0.009085:0.005615:0.011756:0.005615:0.011459:0.009861:0.005045:0.010818:0.005615:0.009861:0.005045:0.006437:0.005615:0.007533:0.007510:0.011345:0.009039:0.005045:0.011071:0.005547:0.009108:0.008994:0.009039:0.007670:0.005045:0.014518:0.009039:0.007442:0.009039:0.005045:0.011391:0.005615:0.009656:0.009039:0.007510:0.006209:0.009108:0.011391:0.005045:0.005615:0.011756:0.004109
AdDF+++ supplemented with 5 µM RHO/ROCK pathway inhibitor (Y-27632) contain-:@0.147059:0.316129:0.882353:0.316129:0.882353:0.295756:0.147059:0.295756:0.014335:0.011391:0.015773:0.011276:0.011779:0.011779:0.011779:0.003766:0.007510:0.011071:0.011048:0.011162:0.005182:0.009039:0.017485:0.009039:0.011391:0.006209:0.009108:0.011391:0.003766:0.014723:0.005271:0.006620:0.011459:0.003766:0.010432:0.002856:0.010957:0.019608:0.003766:0.013376:0.016412:0.016412:0.007099:0.013308:0.016778:0.014678:0.014541:0.003766:0.011365:0.008811:0.006620:0.011071:0.014723:0.008925:0.009724:0.003766:0.005615:0.011870:0.011459:0.005547:0.010820:0.005273:0.006209:0.010843:0.007807:0.003766:0.006825:0.011003:0.007533:0.010432:0.010432:0.010432:0.010432:0.010432:0.006939:0.003766:0.008994:0.010843:0.011391:0.006551:0.009085:0.005615:0.011733:0.007533
ing 0.5–1.0 mg/ml collagenase at 37 °C for 0.5–1.0 h. Ascites/pleural effusion samples :@0.147059:0.336707:0.886459:0.336707:0.886459:0.316334:0.147059:0.316334:0.005615:0.011459:0.009861:0.006688:0.010432:0.004497:0.010432:0.011801:0.010432:0.004497:0.010432:0.002853:0.017348:0.009861:0.007099:0.017759:0.005250:0.006688:0.008994:0.010934:0.005387:0.005433:0.009199:0.009656:0.009039:0.011687:0.009291:0.007875:0.009039:0.006688:0.008811:0.006437:0.006688:0.010432:0.010432:0.002853:0.007442:0.014678:0.006688:0.006026:0.010843:0.007807:0.006688:0.010432:0.004497:0.010432:0.011801:0.010432:0.004497:0.010432:0.002853:0.011459:0.004497:0.006688:0.014586:0.007875:0.008994:0.005273:0.006209:0.009039:0.007670:0.007099:0.011162:0.005182:0.009131:0.011413:0.007898:0.009402:0.005250:0.006688:0.009039:0.005969:0.006127:0.011413:0.007604:0.005547:0.010840:0.011756:0.006688:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.004109
were centrifuged, and washed with AdDF+++. The cell pellet was allocated fixation in :@0.147059:0.357286:0.886484:0.357286:0.886484:0.336913:0.147059:0.336913:0.014518:0.009039:0.007442:0.009039:0.005912:0.008994:0.009039:0.011391:0.006437:0.007807:0.005615:0.006369:0.011413:0.009656:0.009108:0.011117:0.004497:0.005912:0.009085:0.011596:0.011391:0.005912:0.014723:0.009291:0.007556:0.011299:0.009108:0.011391:0.005912:0.014723:0.005273:0.006620:0.011459:0.005912:0.014335:0.011391:0.015773:0.011276:0.011779:0.011779:0.011779:0.004497:0.005912:0.011470:0.011311:0.009039:0.005912:0.008994:0.008948:0.005387:0.005250:0.005912:0.011505:0.008948:0.005387:0.005182:0.009131:0.006437:0.005912:0.014723:0.009291:0.007670:0.005912:0.009405:0.005385:0.005184:0.011274:0.009108:0.008811:0.006209:0.009108:0.011391:0.005912:0.005684:0.005684:0.010089:0.008811:0.006437:0.005547:0.010843:0.011756:0.005912:0.005615:0.011756:0.004109
formalin, DNA isolation and organoid derivation. To eliminate erythrocytes, the samples :@0.147059:0.377865:0.886418:0.377865:0.886418:0.357492:0.147059:0.357492:0.006026:0.010843:0.007807:0.017577:0.009405:0.005250:0.005615:0.011756:0.004497:0.003127:0.015773:0.015408:0.014929:0.003127:0.005615:0.007873:0.010934:0.005433:0.008811:0.006437:0.005547:0.010843:0.011756:0.003127:0.009085:0.011598:0.011391:0.003127:0.010845:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.003127:0.011322:0.009039:0.007807:0.005547:0.009838:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.003127:0.010866:0.011048:0.003127:0.008946:0.005250:0.005615:0.017645:0.005615:0.011687:0.008811:0.006209:0.009039:0.003127:0.009039:0.008400:0.009724:0.006620:0.011459:0.007442:0.011276:0.009382:0.009724:0.006209:0.009039:0.007670:0.004497:0.003127:0.006620:0.011299:0.009039:0.003127:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.004109
for organoid derivation were incubated with 2 ml red blood cell lysis buffer for 5 min at :@0.147059:0.398444:0.886464:0.398444:0.886464:0.378071:0.147059:0.378071:0.006026:0.010843:0.007807:0.004771:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.004771:0.011322:0.009039:0.007807:0.005547:0.009838:0.008811:0.006437:0.005547:0.010843:0.011756:0.004771:0.014518:0.009039:0.007442:0.009039:0.004771:0.005615:0.011596:0.009108:0.011345:0.011117:0.008811:0.006209:0.009108:0.011391:0.004771:0.014723:0.005273:0.006617:0.011459:0.004771:0.010432:0.002856:0.017759:0.005250:0.004771:0.007442:0.009108:0.011391:0.004771:0.010911:0.005182:0.011276:0.011274:0.011391:0.004771:0.008994:0.008948:0.005387:0.005250:0.004771:0.005182:0.009724:0.007601:0.005615:0.007670:0.004771:0.010797:0.011413:0.005969:0.005787:0.009039:0.007807:0.004771:0.006026:0.010843:0.007807:0.004771:0.010432:0.002856:0.017645:0.005615:0.011756:0.004771:0.008811:0.006437:0.004109
room temperature followed by an additional wash with 10 ml AdDF+++ and centrifuga-:@0.147059:0.419022:0.882353:0.419022:0.882353:0.398649:0.147059:0.398649:0.007442:0.011276:0.010843:0.017645:0.003744:0.006209:0.009039:0.017280:0.011505:0.009039:0.007898:0.008811:0.006163:0.011413:0.007442:0.009039:0.003744:0.006026:0.010934:0.005387:0.005182:0.010866:0.014518:0.009108:0.011391:0.003744:0.010840:0.009724:0.003744:0.009087:0.011756:0.003744:0.009291:0.011322:0.011391:0.005273:0.006437:0.005547:0.010843:0.011687:0.009405:0.005250:0.003744:0.014723:0.009291:0.007556:0.011459:0.003744:0.014723:0.005273:0.006620:0.011459:0.003744:0.010432:0.010432:0.002876:0.017759:0.005250:0.003744:0.014335:0.011391:0.015773:0.011276:0.011779:0.011779:0.011779:0.003744:0.009085:0.011598:0.011391:0.003744:0.008994:0.009039:0.011391:0.006437:0.007807:0.005615:0.006369:0.011413:0.009861:0.009309:0.007533
tion at 300g for 5 minutes. Finally, the cells were embedded in BME (Cultrex growth fac-:@0.147059:0.439601:0.882353:0.439601:0.882353:0.419228:0.147059:0.419228:0.006437:0.005547:0.010843:0.011756:0.003744:0.008811:0.006437:0.003744:0.010432:0.010432:0.010432:0.009861:0.003744:0.006026:0.010843:0.007807:0.003744:0.010432:0.003744:0.017645:0.005615:0.011391:0.011071:0.006209:0.009039:0.007670:0.004497:0.003744:0.011391:0.005615:0.011687:0.009405:0.005387:0.005182:0.007989:0.004497:0.003744:0.006620:0.011302:0.009039:0.003744:0.008994:0.008948:0.005387:0.005250:0.007670:0.003744:0.014518:0.009039:0.007442:0.009039:0.003744:0.009039:0.017394:0.011254:0.009108:0.011322:0.011322:0.009106:0.011391:0.003744:0.005615:0.011756:0.003744:0.012646:0.019608:0.012098:0.003744:0.006939:0.014267:0.011548:0.004908:0.006437:0.007442:0.009108:0.010089:0.003744:0.009861:0.007442:0.010866:0.014723:0.006620:0.011459:0.003744:0.006209:0.009291:0.009108:0.007533
tor reduced BME type 2) on ice and seeded on pre-warmed 24-well suspension culture :@0.147059:0.460180:0.886496:0.460180:0.886496:0.439807:0.147059:0.439807:0.006209:0.010843:0.007807:0.004896:0.007444:0.009106:0.011048:0.011345:0.008994:0.009108:0.011391:0.004908:0.012646:0.019608:0.012098:0.004896:0.006437:0.009724:0.011505:0.009039:0.004896:0.010432:0.006939:0.004896:0.010843:0.011756:0.004908:0.005547:0.008994:0.009039:0.004896:0.009085:0.011596:0.011391:0.004908:0.007873:0.009108:0.009108:0.011322:0.009108:0.011391:0.004896:0.010845:0.011756:0.004896:0.011071:0.007442:0.009039:0.007533:0.014723:0.009085:0.007807:0.017485:0.009108:0.011391:0.004896:0.010432:0.010432:0.007533:0.014518:0.008948:0.005387:0.005250:0.004896:0.007510:0.011413:0.007510:0.011505:0.009039:0.011619:0.007601:0.005547:0.010843:0.011756:0.004908:0.009106:0.011550:0.004908:0.006163:0.011413:0.007442:0.009039:0.004109
plates. Following BME polymerization, the cells were overlaid with appropriate organoid :@0.147059:0.480758:0.886395:0.480758:0.886395:0.460385:0.147059:0.460385:0.011162:0.005433:0.008811:0.006209:0.009039:0.007670:0.004497:0.003470:0.010683:0.010934:0.005387:0.005182:0.010866:0.014723:0.005615:0.011459:0.009861:0.003470:0.012646:0.019608:0.012098:0.003470:0.011505:0.010934:0.005182:0.009724:0.017488:0.009039:0.007807:0.005615:0.008834:0.008809:0.006437:0.005547:0.010843:0.011756:0.004497:0.003470:0.006620:0.011299:0.009039:0.003470:0.008994:0.008948:0.005387:0.005250:0.007670:0.003470:0.014518:0.009039:0.007442:0.009039:0.003470:0.010866:0.009633:0.009039:0.007601:0.005433:0.009085:0.005547:0.011391:0.003470:0.014723:0.005273:0.006620:0.011459:0.003470:0.008811:0.011048:0.011071:0.007442:0.010820:0.011071:0.007807:0.005798:0.008811:0.006209:0.009039:0.003470:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.004109
culture medium and incubated at 37°C in humidified air containing 5% CO2 (see :@0.147059:0.501337:0.852308:0.501337:0.852308:0.480964:0.147059:0.480964:0.009108:0.011550:0.004908:0.006163:0.011413:0.007442:0.009039:0.005752:0.017485:0.009108:0.011391:0.005273:0.011413:0.017645:0.005752:0.009085:0.011596:0.011391:0.005752:0.005615:0.011596:0.009108:0.011345:0.011117:0.008809:0.006211:0.009106:0.011391:0.005752:0.008811:0.006437:0.005752:0.010432:0.010432:0.007442:0.014678:0.005752:0.005615:0.011756:0.005752:0.011094:0.011413:0.017645:0.005547:0.011391:0.005615:0.005684:0.005613:0.009108:0.011391:0.005752:0.009085:0.005615:0.007807:0.005752:0.008994:0.010843:0.011391:0.006551:0.009085:0.005615:0.011756:0.005615:0.011459:0.009861:0.005752:0.010432:0.015043:0.005752:0.014746:0.016412:0.010432:0.005752:0.006939:0.007873:0.009108:0.009039:0.004109
Ta-:@0.853865:0.501337:0.882353:0.501337:0.882353:0.480204:0.853865:0.480204:0.011413:0.009861:0.007213
ble S1:@0.147059:0.521916:0.199423:0.521916:0.199423:0.500783:0.147059:0.500783:0.011528:0.005935:0.009473:0.003926:0.010592:0.010911
). PDO names are informative of histological subtype, patient and tumor location. :@0.199432:0.521916:0.886384:0.521916:0.886384:0.501543:0.199432:0.501543:0.006939:0.004497:0.004018:0.011664:0.016504:0.016412:0.004018:0.011687:0.009085:0.017485:0.009039:0.007670:0.004018:0.009085:0.007442:0.009039:0.004018:0.005615:0.011756:0.006026:0.010843:0.007807:0.017577:0.008811:0.006437:0.005547:0.009633:0.009039:0.004018:0.010843:0.006209:0.004018:0.011459:0.005615:0.007510:0.006209:0.010934:0.005182:0.011048:0.009861:0.005547:0.009108:0.009405:0.005250:0.004018:0.007510:0.011345:0.010797:0.006437:0.009724:0.011505:0.008743:0.004497:0.004018:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.004018:0.009085:0.011598:0.011391:0.004018:0.006163:0.011413:0.017485:0.010843:0.007807:0.004018:0.005182:0.011276:0.009108:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.004109
Histological subtype: HGS/LGS=high/low-grade serous adenocarcinoma, HG=high-:@0.147059:0.542494:0.882330:0.542494:0.882330:0.522122:0.147059:0.522122:0.016481:0.005615:0.007510:0.006209:0.010934:0.005182:0.011048:0.009861:0.005547:0.009108:0.009405:0.005250:0.008377:0.007510:0.011345:0.010797:0.006437:0.009724:0.011505:0.009039:0.004497:0.008377:0.016412:0.015682:0.010112:0.007099:0.011528:0.015682:0.010112:0.011779:0.011459:0.005615:0.009927:0.011459:0.007099:0.005182:0.010866:0.014723:0.007533:0.009861:0.007898:0.009291:0.011322:0.009039:0.008377:0.007875:0.009039:0.007442:0.010820:0.011413:0.007670:0.008377:0.009291:0.011322:0.009039:0.011596:0.011276:0.009108:0.009085:0.007442:0.008994:0.005615:0.011596:0.010843:0.017577:0.009291:0.004497:0.008377:0.016412:0.015682:0.011779:0.011459:0.005615:0.009930:0.011459:0.007533
grade adenocarcinoma, SBT/MBT=serous/mucinous borderline tumor, MC=mucinous :@0.147059:0.563073:0.886441:0.563073:0.886441:0.542700:0.147059:0.542700:0.009861:0.007898:0.009291:0.011322:0.009039:0.003881:0.009291:0.011322:0.009039:0.011596:0.011276:0.009108:0.009085:0.007442:0.008994:0.005615:0.011596:0.010843:0.017577:0.009291:0.004497:0.003881:0.009770:0.012393:0.013354:0.007099:0.019608:0.012395:0.013354:0.011779:0.007875:0.009039:0.007442:0.010820:0.011413:0.007670:0.007099:0.017280:0.011345:0.008994:0.005615:0.011596:0.010820:0.011413:0.007670:0.003881:0.011254:0.010843:0.007442:0.011322:0.009039:0.007601:0.005250:0.005615:0.011596:0.009039:0.003881:0.006163:0.011413:0.017485:0.010843:0.006255:0.004497:0.003881:0.019197:0.014678:0.011779:0.017280:0.011345:0.008994:0.005615:0.011598:0.010820:0.011413:0.007670:0.004109
adenocarcinoma, CCC=clear cell carcinoma, END=endometrioid carcinoma. The first :@0.147059:0.583652:0.886510:0.583652:0.886510:0.563279:0.147059:0.563279:0.009291:0.011322:0.009039:0.011596:0.011276:0.009108:0.009085:0.007442:0.008994:0.005615:0.011596:0.010843:0.017577:0.009291:0.004497:0.005433:0.014746:0.014746:0.014678:0.011779:0.008765:0.005182:0.009288:0.009087:0.007807:0.005433:0.008994:0.008948:0.005387:0.005250:0.005433:0.009106:0.009087:0.007442:0.008994:0.005615:0.011596:0.010843:0.017577:0.009291:0.004497:0.005433:0.012098:0.016230:0.016139:0.011779:0.009039:0.011596:0.011322:0.010843:0.017485:0.009131:0.006437:0.007807:0.005547:0.010843:0.005547:0.011391:0.005433:0.009108:0.009085:0.007442:0.008994:0.005615:0.011596:0.010843:0.017577:0.009291:0.004497:0.005433:0.011470:0.011311:0.009039:0.005433:0.005684:0.005684:0.007624:0.007510:0.006437:0.004109
number indicates the patient, the second number indicates tumor location.:@0.147059:0.604231:0.775019:0.604231:0.775019:0.583858:0.147059:0.583858:0.011391:0.011413:0.017394:0.011254:0.009039:0.007807:0.004109:0.005615:0.011596:0.011391:0.005547:0.009108:0.008811:0.006209:0.009039:0.007670:0.004109:0.006617:0.011302:0.009039:0.004109:0.011365:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.004497:0.004109:0.006620:0.011299:0.009039:0.004109:0.007875:0.009108:0.008994:0.010843:0.011596:0.011391:0.004109:0.011391:0.011413:0.017394:0.011254:0.009039:0.007807:0.004109:0.005615:0.011596:0.011391:0.005545:0.009108:0.008811:0.006209:0.009039:0.007670:0.004109:0.006163:0.011413:0.017485:0.010843:0.007807:0.004109:0.005182:0.011276:0.009108:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497
 :@0.221765:0.641657:0.227533:0.641657:0.227533:0.625465:0.221765:0.625465:0.005769
METHOD DETAILS:@0.147059:0.663613:0.302660:0.663613:0.302660:0.636593:0.147059:0.636593:0.017286:0.010924:0.010052:0.013509:0.013132:0.013103:0.004648:0.013103:0.010924:0.008771:0.012318:0.005665:0.010023:0.012144
In vitro PDO drug response testing:@0.147059:0.686661:0.455987:0.686661:0.455987:0.663502:0.147059:0.663502:0.004856:0.011679:0.003735:0.010160:0.004856:0.008616:0.011079:0.011256:0.003984:0.010733:0.011231:0.011256:0.003984:0.011231:0.011156:0.011156:0.011206:0.003984:0.011231:0.009214:0.010409:0.010733:0.011256:0.011679:0.010409:0.009363:0.003984:0.008616:0.009211:0.010309:0.008616:0.004856:0.011679:0.011206
PDO drug response testing was performed as previously described . In short, PDOs :@0.147059:0.712416:0.886448:0.712416:0.886448:0.692043:0.147059:0.692043:0.011664:0.016504:0.016412:0.006095:0.011391:0.007967:0.011413:0.009861:0.006095:0.007442:0.009039:0.007510:0.011505:0.010843:0.011619:0.007875:0.009039:0.006095:0.006209:0.009039:0.007510:0.006437:0.005615:0.011459:0.009861:0.006095:0.014723:0.009291:0.007670:0.006095:0.011505:0.009039:0.007807:0.006026:0.010843:0.007807:0.017485:0.009108:0.011391:0.006095:0.009291:0.007670:0.006095:0.011071:0.007442:0.009336:0.009838:0.005547:0.010820:0.011413:0.007556:0.005182:0.009724:0.006095:0.011322:0.009039:0.007873:0.008994:0.007807:0.005547:0.011254:0.009108:0.011391:0.018273:0.004497:0.006095:0.006891:0.011756:0.006095:0.007556:0.011299:0.010843:0.007967:0.006437:0.004497:0.006095:0.011664:0.016504:0.016253:0.007670:0.004109
278:@0.721977:0.704800:0.740223:0.704800:0.740223:0.692922:0.721977:0.692922:0.006082:0.006082:0.006082
were exposed to drugs in varying concentrations and to controls (DMSO, ABT-263/:@0.147059:0.732994:0.882234:0.732994:0.882234:0.712622:0.147059:0.712622:0.014518:0.009039:0.007442:0.009039:0.006985:0.009106:0.010089:0.011505:0.010957:0.007875:0.009108:0.011391:0.006985:0.006209:0.011048:0.006985:0.011391:0.007967:0.011413:0.009724:0.007670:0.006985:0.005615:0.011756:0.006985:0.009838:0.009085:0.008398:0.009724:0.005615:0.011459:0.009861:0.006985:0.008994:0.010843:0.011596:0.008994:0.009039:0.011391:0.006437:0.007898:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.006985:0.009085:0.011596:0.011391:0.006985:0.006209:0.011048:0.006985:0.008994:0.010843:0.011391:0.006437:0.007442:0.010934:0.005250:0.007670:0.006985:0.006939:0.015497:0.019608:0.010112:0.015385:0.004497:0.006985:0.014929:0.012395:0.011801:0.007533:0.010432:0.010432:0.010432:0.007099
navitoclax) for 120 hours in 384-well plates, after which ATP levels were measured with :@0.147059:0.753573:0.886468:0.753573:0.886468:0.733200:0.147059:0.733200:0.011687:0.008925:0.009838:0.005273:0.006209:0.011276:0.008765:0.005433:0.009291:0.010089:0.006939:0.004417:0.006026:0.010843:0.007807:0.004417:0.010432:0.010432:0.010432:0.004417:0.011299:0.010822:0.011413:0.007624:0.007670:0.004417:0.005615:0.011756:0.004417:0.010432:0.010432:0.010432:0.007533:0.014518:0.008948:0.005387:0.005250:0.004417:0.011162:0.005433:0.008811:0.006209:0.009039:0.007670:0.004497:0.004417:0.009085:0.006197:0.005969:0.009039:0.007807:0.004428:0.014789:0.011459:0.005549:0.008765:0.011459:0.004417:0.013513:0.013354:0.012167:0.004417:0.005182:0.009336:0.009633:0.008948:0.005250:0.007670:0.004417:0.014520:0.009039:0.007442:0.009039:0.004417:0.017485:0.009291:0.009291:0.007510:0.011413:0.007442:0.009108:0.011391:0.004417:0.014723:0.005273:0.006620:0.011459:0.004109
the Cell-Titer Glo2.0 assay. All screens were performed in technical replicates. Biolog-:@0.147059:0.774152:0.882353:0.774152:0.882353:0.753779:0.147059:0.753779:0.006620:0.011299:0.009039:0.005730:0.014995:0.008948:0.005387:0.005250:0.007533:0.012737:0.005273:0.006209:0.009039:0.007807:0.005730:0.015499:0.005182:0.011048:0.010432:0.004497:0.010432:0.005730:0.009291:0.007533:0.007944:0.008925:0.007989:0.004497:0.005730:0.015066:0.005387:0.005250:0.005730:0.007875:0.008994:0.007442:0.009108:0.009039:0.011619:0.007670:0.005730:0.014518:0.009039:0.007442:0.009039:0.005730:0.011502:0.009039:0.007807:0.006026:0.010843:0.007807:0.017488:0.009106:0.011391:0.005730:0.005615:0.011756:0.005730:0.006209:0.009108:0.008765:0.011459:0.011756:0.005547:0.009108:0.009405:0.005250:0.005730:0.007442:0.009131:0.011162:0.005250:0.005547:0.009108:0.008811:0.006209:0.009039:0.007670:0.004497:0.005730:0.012486:0.005547:0.010934:0.005182:0.011048:0.009795:0.007533
ical replicates were performed in a subset of PDOs and drugs (:@0.147059:0.794731:0.683258:0.794731:0.683258:0.774358:0.147059:0.774358:0.005547:0.009108:0.009405:0.005250:0.005478:0.007442:0.009131:0.011162:0.005250:0.005547:0.009108:0.008811:0.006209:0.009039:0.007670:0.005478:0.014518:0.009039:0.007442:0.009039:0.005478:0.011505:0.009039:0.007807:0.006026:0.010843:0.007807:0.017485:0.009108:0.011391:0.005478:0.005615:0.011756:0.005478:0.009291:0.005478:0.007510:0.011345:0.010934:0.007875:0.009131:0.006437:0.005478:0.010843:0.006209:0.005478:0.011664:0.016501:0.016255:0.007670:0.005478:0.009085:0.011596:0.011391:0.005478:0.011391:0.007964:0.011413:0.009724:0.007670:0.005478:0.006939
Table S4:@0.683192:0.794731:0.758064:0.794731:0.758064:0.773598:0.683192:0.773598:0.011413:0.009679:0.011528:0.005935:0.009473:0.005341:0.010592:0.010911
) to investigate :@0.758073:0.794731:0.886474:0.794731:0.886474:0.774358:0.758073:0.774358:0.006939:0.005478:0.006209:0.011048:0.005478:0.005615:0.011368:0.009633:0.009039:0.007510:0.006437:0.005615:0.009861:0.008811:0.006209:0.009039:0.004109
biological variation. Results were normalized to vehicle (DMSO = 100%) and baseline :@0.147059:0.815309:0.886462:0.815309:0.886462:0.794936:0.147059:0.794936:0.010820:0.005547:0.010934:0.005182:0.011048:0.009861:0.005547:0.009108:0.009405:0.005250:0.005784:0.009838:0.009085:0.007807:0.005798:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.005787:0.013694:0.009039:0.007512:0.011550:0.004905:0.006437:0.007670:0.005787:0.014518:0.009039:0.007442:0.009039:0.005787:0.011596:0.010843:0.007807:0.017577:0.009405:0.005250:0.005615:0.008834:0.009106:0.011391:0.005787:0.006209:0.011048:0.005784:0.009635:0.008948:0.011459:0.005547:0.008765:0.005182:0.009039:0.005784:0.006939:0.015499:0.019608:0.010112:0.016412:0.005784:0.011779:0.005787:0.010432:0.010432:0.010432:0.015043:0.006939:0.005787:0.009085:0.011596:0.011391:0.005787:0.011114:0.009291:0.007875:0.008948:0.005250:0.005615:0.011596:0.009039:0.004109
control (ABT-263/navitoclax 20 μM). Data was analyzed using GraphPad Prism 6. Drug :@0.147059:0.835888:0.886370:0.835888:0.886370:0.815515:0.147059:0.815515:0.008994:0.010843:0.011391:0.006437:0.007442:0.010934:0.005250:0.003789:0.006939:0.014929:0.012395:0.011801:0.007533:0.010432:0.010432:0.010432:0.007099:0.011685:0.008925:0.009838:0.005273:0.006209:0.011276:0.008765:0.005433:0.009291:0.010089:0.003789:0.010432:0.010432:0.003789:0.010957:0.019608:0.006939:0.004497:0.003789:0.016207:0.008811:0.006549:0.009291:0.003789:0.014723:0.009291:0.007670:0.003789:0.009085:0.011687:0.009405:0.005182:0.009724:0.008834:0.009108:0.011391:0.003789:0.011413:0.007601:0.005615:0.011459:0.009861:0.003789:0.015477:0.007898:0.008811:0.011162:0.011459:0.011413:0.009291:0.011391:0.003789:0.011916:0.007807:0.005615:0.007604:0.017645:0.003789:0.010432:0.004497:0.003789:0.016024:0.007967:0.011413:0.009861:0.004109
dose-response curves were visualized using linear regression analysis (setting: log(in-:@0.147059:0.856467:0.882353:0.856467:0.882353:0.836094:0.147059:0.836094:0.011322:0.010957:0.007875:0.009039:0.007533:0.007442:0.009039:0.007510:0.011505:0.010843:0.011619:0.007875:0.009039:0.006848:0.009108:0.011413:0.008398:0.009635:0.009039:0.007670:0.006848:0.014518:0.009039:0.007442:0.009039:0.006848:0.009838:0.005615:0.007510:0.011596:0.009405:0.005250:0.005615:0.008834:0.009108:0.011391:0.006848:0.011413:0.007601:0.005615:0.011459:0.009861:0.006848:0.005250:0.005615:0.011596:0.009291:0.009085:0.007807:0.006848:0.007442:0.009039:0.009861:0.007442:0.009039:0.007533:0.007601:0.005547:0.010843:0.011756:0.006848:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.006848:0.006939:0.007875:0.009131:0.006163:0.006437:0.005615:0.011461:0.009861:0.004497:0.006848:0.005182:0.011048:0.009861:0.006939:0.005615:0.011774:0.007533
hibitor) vs. response; least squares (ordinary) fit; top constraint 100%). Concentrations :@0.147059:0.877045:0.886487:0.877045:0.886487:0.856672:0.147059:0.856672:0.011459:0.005547:0.010820:0.005273:0.006209:0.010843:0.007807:0.006939:0.005387:0.009838:0.007670:0.004497:0.005387:0.007442:0.009039:0.007510:0.011505:0.010843:0.011619:0.007875:0.009039:0.004497:0.005387:0.005182:0.009291:0.009291:0.007510:0.006437:0.005387:0.007875:0.010706:0.011594:0.009087:0.007442:0.009039:0.007670:0.005387:0.006939:0.010843:0.007442:0.011391:0.005615:0.011687:0.009085:0.008400:0.009724:0.006939:0.005387:0.005684:0.005341:0.006437:0.004497:0.005387:0.006209:0.010820:0.011276:0.005387:0.008994:0.010843:0.011619:0.007510:0.006437:0.007898:0.009085:0.005615:0.011391:0.006437:0.005387:0.010432:0.010432:0.010432:0.015043:0.006939:0.004497:0.005387:0.014997:0.010843:0.011596:0.008994:0.009039:0.011391:0.006437:0.007898:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.004109
where 50% cell viability (IC50-value) was reached were interpolated. The area under the :@0.147059:0.897624:0.886551:0.897624:0.886551:0.877251:0.147059:0.877251:0.014792:0.011299:0.009039:0.007442:0.009039:0.004314:0.010432:0.010432:0.015043:0.004314:0.008994:0.008948:0.005387:0.005250:0.004314:0.009838:0.005798:0.009108:0.010820:0.005752:0.005250:0.005271:0.006437:0.009724:0.004314:0.006939:0.006825:0.014678:0.010432:0.010432:0.007533:0.009838:0.009402:0.004908:0.011345:0.009039:0.006939:0.004314:0.014723:0.009291:0.007670:0.004314:0.007444:0.009288:0.009291:0.008765:0.011302:0.009106:0.011391:0.004314:0.014518:0.009039:0.007442:0.009039:0.004314:0.005615:0.011391:0.006209:0.009039:0.007967:0.011502:0.010936:0.005433:0.008811:0.006209:0.009106:0.011117:0.004497:0.004314:0.011470:0.011311:0.009039:0.004314:0.009085:0.007442:0.009291:0.009291:0.004314:0.011413:0.011596:0.011322:0.009039:0.007807:0.004314:0.006620:0.011302:0.009039:0.004109
curve (AUC) was approximated between the lowest and highest concentrations screened :@0.147059:0.918203:0.886544:0.918203:0.886544:0.897830:0.147059:0.897830:0.009108:0.011413:0.008400:0.009633:0.009039:0.003424:0.006939:0.013513:0.016024:0.014678:0.006939:0.003413:0.014723:0.009291:0.007670:0.003424:0.008811:0.011048:0.011071:0.007442:0.010820:0.010089:0.005615:0.017577:0.008811:0.006209:0.009108:0.011391:0.003424:0.011254:0.009131:0.006437:0.014518:0.009108:0.009039:0.011756:0.003424:0.006617:0.011302:0.009039:0.003424:0.005182:0.010866:0.014518:0.009039:0.007510:0.006437:0.003424:0.009085:0.011596:0.011391:0.003424:0.011459:0.005615:0.009930:0.011299:0.009039:0.007510:0.006437:0.003424:0.008994:0.010843:0.011596:0.008994:0.009039:0.011391:0.006437:0.007898:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.003424:0.007875:0.008994:0.007442:0.009108:0.009039:0.011596:0.009108:0.011391:0.004109